FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is - and the average weighting 5.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,151,886 | -5.9% | 4,729,419 | -1.8% | 0.57% | -6.2% |
| Q4 2022 | $2,287,331 | -32.1% | 4,814,419 | 0.0% | 0.61% | -32.8% |
| Q3 2022 | $3,370,000 | -20.3% | 4,814,419 | -1.0% | 0.91% | -43.9% |
| Q2 2022 | $4,230,000 | -22.3% | 4,862,319 | 0.0% | 1.62% | -30.2% |
| Q1 2022 | $5,446,000 | +46.6% | 4,862,319 | +159.1% | 2.32% | +87.8% |
| Q4 2021 | $3,715,000 | -23.7% | 1,876,389 | +31.4% | 1.23% | -13.2% |
| Q3 2021 | $4,867,000 | -56.7% | 1,427,481 | +3.5% | 1.42% | -45.7% |
| Q2 2021 | $11,246,000 | -34.0% | 1,379,843 | -0.4% | 2.62% | -23.3% |
| Q1 2021 | $17,033,000 | -31.5% | 1,384,743 | +1.7% | 3.41% | -51.3% |
| Q4 2020 | $24,853,000 | +20.2% | 1,361,064 | +2.8% | 7.00% | -4.8% |
| Q3 2020 | $20,673,000 | – | 1,324,364 | – | 7.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,508 | $3,783,591 | 5.70% |